Risk of gastrointestinal bleeding with direct oral anticoagulants: a systematic review and network meta-analysis
- 1 February 2017
- journal article
- research article
- Published by Elsevier in The Lancet Gastroenterology & Hepatology
- Vol. 2 (2) , 85-93
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Andexanet Alfa for the Reversal of Factor Xa Inhibitor ActivityNew England Journal of Medicine, 2015
- National Trends in Ambulatory Oral Anticoagulant UseThe American Journal of Medicine, 2015
- Idarucizumab for Dabigatran ReversalNew England Journal of Medicine, 2015
- Recommendation on the nomenclature for oral anticoagulants: communication from the SSC of the ISTHJournal of Thrombosis and Haemostasis, 2015
- Systematic review and network meta-analysis comparing antithrombotic agents for the prevention of stroke and major bleeding in patients with atrial fibrillationBMJ Open, 2014
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trialsThe Lancet, 2014
- Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysisBMJ, 2013
- The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) StudyCirculation, 2013
- Major haemorrhagic complications during oral anticoagulant therapy in a Danish Population‐based cohortJournal of Internal Medicine, 1997
- Bleeding and Thromboembolism During Anticoagulant Therapy:A Population-Based Study in Rochester, MinnesotaMayo Clinic Proceedings, 1995